Welcome to our dedicated page for Hyperliquid Strategies SEC filings (Ticker: PURR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page is intended to provide access to SEC filings for Hyperliquid Strategies Inc (NASDAQ: PURR), a company that describes itself as a digital asset treasury business focused on accumulating HYPE, the native token of the Hyperliquid blockchain. While specific filings may vary over time, SEC documents are the primary source for detailed information about the company’s operations, risks, and capital structure.
In its public descriptions, Hyperliquid Strategies Inc highlights activities such as staking, yield optimization, and active engagement in the Hyperliquid ecosystem as part of its approach to generating returns from HYPE. When available, core filings such as annual reports on Form 10-K and quarterly reports on Form 10-Q can provide additional context on how these activities are reflected in the company’s financial statements, risk factors, and management discussion.
For investors tracking PURR, SEC filings can also shed light on matters such as stock repurchase programs authorized by the Board of Directors, the company’s use of cash in connection with its HYPE-focused strategy, and other capital allocation decisions. Current reports on Form 8-K, when filed, may discuss material events, including changes to repurchase authorizations or other significant corporate actions.
Stock Titan enhances access to these documents with AI-powered summaries
Bhatt Nailesh reported acquisition or exercise transactions in this Form 4 filing.
Hyperliquid Strategies Inc director Bhatt Nailesh received 2,455 restricted shares of common stock as compensation. The shares were granted on April 1, 2026 at a stated price of $0.00 per share, reflecting an equity award rather than a market purchase.
According to the footnote, Nailesh elected to receive these restricted shares instead of cash under Hyperliquid Strategies Inc's 2025 Equity Incentive Plan. After this award, he directly holds 45,326 shares of common stock. This is a routine director compensation grant, not an open-market buy or sale.
Rosengren Eric S reported acquisition or exercise transactions in this Form 4 filing.
Hyperliquid Strategies Inc director Eric S. Rosengren received a grant of 7,367 restricted shares of common stock as compensation in lieu of cash under the company’s 2025 Equity Incentive Plan. Following this award, he directly holds 72,036 shares of Hyperliquid Strategies common stock.
KING THOMAS C. reported acquisition or exercise transactions in this Form 4 filing.
Hyperliquid Strategies Inc director Thomas C. King received a grant of 7,367 restricted shares of common stock as compensation in lieu of cash. The award was made under the company’s 2025 Equity Incentive Plan and increased his directly held common stock to 72,036 shares.
LEIBOWITZ LAWRENCE E reported acquisition or exercise transactions in this Form 4 filing.
Hyperliquid Strategies Inc director Lawrence E. Leibowitz received a grant of 3,274 restricted shares of common stock. The shares were taken as compensation in lieu of cash under the company’s 2025 Equity Incentive Plan and were reported at a price of $0.00 per share.
After this award, Leibowitz directly holds 83,863 shares of common stock. This is a routine, compensation-related equity grant rather than an open-market purchase or sale.
Hyperliquid Strategies Inc filed an amended current report to add detailed financial information for its completed business combination with Sonnet BioTherapeutics Holdings, Inc. The amendment supplies Sonnet’s audited financial statements for the fiscal year ended September 30, 2025 and related notes.
The filing also includes unaudited pro forma condensed combined financial statements showing how Hyperliquid and Sonnet’s finances would look on a combined basis as of and for the period ended September 30, 2025. Management emphasizes these pro forma figures are for informational purposes only and are not intended to represent actual or future results.
D1 Capital Partners L.P. and Daniel Sundheim report beneficial ownership of 8,000,000 shares of Hyperliquid Strategies Inc., representing 6.3% of the common stock. The stake is held through D1’s investment vehicle, with shared voting and dispositive power and no sole authority reported.
The ownership percentage is based on 127,025,563 shares of common stock reported outstanding as of December 5, 2025 in Hyperliquid’s Form 10-Q for the quarter ended September 30, 2025. The investors certify the position is held in the ordinary course of business and not for the purpose of changing or influencing control.
Hyperliquid Strategies Inc. has registered the resale of up to 160,000,000 shares of common stock that may be offered from time to time by Chardan Capital Markets LLC under an existing equity facility. The company’s stock trades on Nasdaq under the symbol PURR.
Hyperliquid operates as a cryptocurrency treasury company focused on holding and staking HYPE, the native token of the Hyperliquid Layer-1 blockchain, while continuing legacy biotech activities via its Sonnet subsidiary. As of December 31, 2025, it held HYPE digital assets with a fair value of $327.6 million and cash and cash equivalents of $281.9 million, supporting total assets of $616.6 million.
For the three months ended December 31, 2025, revenue was $0.5 million from net staking rewards. The company reported a net loss of $304.5 million, driven largely by a $93.2 million unrealized loss on HYPE tokens, a $155.8 million loss on a HYPE contribution commitment, and a $35.6 million in-process R&D write-off from the Sonnet acquisition. Management states that capital raised through a PIPE financing and the equity facility has alleviated prior substantial doubt about its ability to continue as a going concern for at least one year.
Hyperliquid Strategies Inc CEO and director David Ira Schamis reported an equity award in the company’s common stock. On February 9, 2026, he acquired 40,789 shares at a price of $0 through a grant classified as a “grant, award, or other acquisition.”
After this award, he directly beneficially owned 136,309 shares of common stock. The grant represents restricted stock units scheduled to vest over three years, with one-third vesting on December 2, 2026, one-third on December 2, 2027, and one-third on December 2, 2028.
Hyperliquid Strategies Inc director Jeffrey Tuder reported an equity award. On February 9, 2026, he acquired 40,789 shares of common stock at a price of $0 through a grant classified as a restricted stock unit award. These restricted stock units are scheduled to vest over three years, with one-third vesting on each of December 2, 2026, December 2, 2027, and December 2, 2028. After this grant, he holds 40,789 shares directly and 8,188 shares indirectly through Tremson Capital Management, LLC, for which he disclaims beneficial ownership except for his pecuniary interest.
Hyperliquid Strategies Inc director Albert D. Dyrness reported receiving a grant of 40,789 restricted stock units (RSUs) of common stock on February 9, 2026 at a price of $0 per unit. Following this award, he beneficially owns 41,671 common shares.
The RSUs are scheduled to vest over three years, with one-third vesting on each of December 2, 2026, December 2, 2027, and December 2, 2028. The filing characterizes the transaction as a grant, award, or other acquisition of shares held directly.